Free Trial
NASDAQ:DTIL

Precision BioSciences (DTIL) Stock Price, News & Analysis

Precision BioSciences logo
$4.38 -0.19 (-4.16%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$4.33 -0.05 (-1.23%)
As of 08/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Precision BioSciences Stock (NASDAQ:DTIL)

Key Stats

Today's Range
$4.30
$4.66
50-Day Range
$4.13
$5.49
52-Week Range
$3.61
$11.09
Volume
87,285 shs
Average Volume
210,494 shs
Market Capitalization
$48.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.00
Consensus Rating
Buy

Company Overview

Precision BioSciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

DTIL MarketRank™: 

Precision BioSciences scored higher than 85% of companies evaluated by MarketBeat, and ranked 148th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Precision BioSciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Precision BioSciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Precision BioSciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Precision BioSciences are expected to grow in the coming year, from ($1.23) to ($1.05) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Precision BioSciences is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Precision BioSciences is -0.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Precision BioSciences has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    13.33% of the float of Precision BioSciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Precision BioSciences has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Precision BioSciences has recently decreased by 16.92%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Precision BioSciences does not currently pay a dividend.

  • Dividend Growth

    Precision BioSciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.33% of the float of Precision BioSciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Precision BioSciences has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Precision BioSciences has recently decreased by 16.92%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Precision BioSciences has a news sentiment score of -0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Precision BioSciences this week, compared to 2 articles on an average week.
  • Search Interest

    Only 8 people have searched for DTIL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Precision BioSciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Precision BioSciences insiders have sold 807.12% more of their company's stock than they have bought. Specifically, they have bought $6,963.00 in company stock and sold $63,163.00 in company stock.

  • Percentage Held by Insiders

    Only 4.50% of the stock of Precision BioSciences is held by insiders.

  • Percentage Held by Institutions

    Only 37.99% of the stock of Precision BioSciences is held by institutions.

  • Read more about Precision BioSciences' insider trading history.
Receive DTIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precision BioSciences and its competitors with MarketBeat's FREE daily newsletter.

DTIL Stock News Headlines

DTIL Revenue Drops 99%
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
See More Headlines

DTIL Stock Analysis - Frequently Asked Questions

Precision BioSciences' stock was trading at $3.81 on January 1st, 2025. Since then, DTIL shares have increased by 15.0% and is now trading at $4.38.

Precision BioSciences, Inc. (NASDAQ:DTIL) announced its earnings results on Thursday, August, 7th. The company reported ($2.13) earnings per share for the quarter, missing the consensus estimate of ($0.09) by $2.04. The business earned $0.02 million during the quarter, compared to analysts' expectations of $6.27 million. Precision BioSciences had a negative net margin of 6,205.79% and a negative trailing twelve-month return on equity of 158.77%.

Precision BioSciences's stock reverse split on Wednesday, February 14th 2024.The 1-30 reverse split was announced on Wednesday, February 14th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Precision BioSciences (DTIL) raised $126 million in an IPO on Thursday, March 28th 2019. The company issued 7,900,000 shares at $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs, Jefferies and Barclays acted as the underwriters for the IPO.

Precision BioSciences' top institutional investors include Geode Capital Management LLC (0.70%). Insiders that own company stock include J Jefferson Smith, John Alexander Kelly, Melinda Brown, Geno J Germano, Dario Scimeca and Alan List.
View institutional ownership trends
.

Shares of DTIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Precision BioSciences investors own include Editas Medicine (EDIT), Luminar Technologies (LAZR), CRISPR Therapeutics (CRSP), Enovix (ENVX), Nokia (NOK) and Ginkgo Bioworks (DNA).

Company Calendar

Last Earnings
8/07/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DTIL
CIK
1357874
Fax
N/A
Employees
200
Year Founded
N/A

Price Target and Rating

High Price Target
$60.00
Low Price Target
$34.00
Potential Upside/Downside
+973.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.17 million
Net Margins
-6,205.79%
Pretax Margin
-42.99%
Return on Equity
-158.77%
Return on Assets
-65.42%

Debt

Debt-to-Equity Ratio
0.45
Current Ratio
6.62
Quick Ratio
6.62

Sales & Book Value

Annual Sales
$68.70 million
Price / Sales
0.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.87 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
11,090,000
Free Float
10,589,000
Market Cap
$48.57 million
Optionable
No Data
Beta
1.52

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:DTIL) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners